A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Aim: To assess feasibility, safety and long-term outcome of a water-soluble contrast agent (Gastrografin™) in surgical neonates/infants who present with ABSO. Method: 18 Neonates, who continued to exhibits signs of intestinal obstruction after one week post surgery, were given 1-2 mls/kg of oral Gastrografin for 5-8 days. Result: All but one patient could be fed within 12 hours and discharged home soon afterwards. A single patient retuned 6 months later with ABSO and was similarly treateddoi:10.36346/sarjams.2019.v01i03.001 fatcat:vmjgs4sdlzeg3jdfapaoyw646q